▶ 調査レポート

体外炎症性腸疾患診断の世界市場2020-2030:製品別(アッセイ/バイオマーカー、アナライザー)、エンドユーザー別

• 英文タイトル:In-vitro Inflammatory Bowel Disease Diagnostic Market (Product: Assays/Biomarker and Analyzers; and End User: Diagnostic Laboratories, Hospitals, and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Transparency Market Researchが調査・発行した産業分析レポートです。体外炎症性腸疾患診断の世界市場2020-2030:製品別(アッセイ/バイオマーカー、アナライザー)、エンドユーザー別 / In-vitro Inflammatory Bowel Disease Diagnostic Market (Product: Assays/Biomarker and Analyzers; and End User: Diagnostic Laboratories, Hospitals, and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030 / D0SP21038資料のイメージです。• レポートコード:D0SP21038
• 出版社/出版日:Transparency Market Research / 2020年7月31日
• レポート形態:英文、PDF、164ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥614,270 (USD5,795)▷ お問い合わせ
  Multi User¥932,270 (USD8,795)▷ お問い合わせ
  Corporate License¥1,250,270 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、体外炎症性腸疾患診断の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、製品別(アッセイ/バイオマーカー、アナライザー)分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)分析、競争状況などの構成でお届けいたします。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場動向
・体外炎症性腸疾患診断の世界市場:製品別(アッセイ/バイオマーカー、アナライザー)
・体外炎症性腸疾患診断の世界市場:エンドユーザー別
・体外炎症性腸疾患診断の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)
・競争状況

In-vitro Inflammatory Bowel Disease Diagnostic Market – Scope of the Report

TMR’s report on the global in-vitro inflammatory bowel disease diagnostic market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global in-vitro inflammatory bowel disease diagnostic market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro inflammatory bowel disease diagnostic market from 2020 to 2030.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global in-vitro inflammatory bowel disease diagnostic market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro inflammatory bowel disease diagnostic market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global in-vitro inflammatory bowel disease diagnostic market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro inflammatory bowel disease diagnostic market.

The report also delves into the competition landscape of the global in-vitro inflammatory bowel disease diagnostic market. Key players operating in the global in-vitro inflammatory bowel disease diagnostic market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global in-vitro inflammatory bowel disease diagnostic market that have been profiled in this report.

Key Questions Answered in In-vitro Inflammatory Bowel Disease Diagnostic Market Report

What is the sales/revenue generated by in-vitro inflammatory bowel disease diagnostic products across all regions during the forecast period?
What are the opportunities in the global in-vitro inflammatory bowel disease diagnostic market?
What are the major drivers, restraints, opportunities, and threats in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which product segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
In-vitro Inflammatory Bowel Disease Diagnostic Market – Research Objectives and Research Approach

The comprehensive report on the global in-vitro inflammatory bowel disease diagnostic market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in-vitro inflammatory bowel disease diagnostic market in terms of product, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global in-vitro inflammatory bowel disease diagnostic market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In-vitro Inflammatory Bowel Disease Diagnostic Market

4. Market Overview

4.1. Introduction & Overview

4.2. Product Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, 2018–2030

5. Market Outlook

5.1. Disease Prevalence & Incidence Rate globally with key countries

5.2. Key Industry Developments

5.3. Fecal Biomarkers – Advancement

6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by Product

6.1. Introduction & Definition

6.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

6.2.1. Assays/Biomarker

6.2.1.1. Calprotectin

6.2.1.2. Lactoferrin

6.2.1.3. Bile Acids

6.2.1.4. H. pylori SA

6.2.1.5. Pancreatic Elastase

6.2.1.6. Others

6.2.2. Analyzers

6.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by Product

7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by End-user

7.1. Introduction & Definition

7.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$) Forecast, by End-user, 2018–2030

7.2.1. Diagnostic Laboratories

7.2.2. Hospitals

7.2.3. Research Institutes

7.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by End-user

8. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis, by Region

9. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

9.1. Introduction

9.2. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

9.2.1. Assays/Biomarker

9.2.1.1. Calprotectin

9.2.1.2. Lactoferrin

9.2.1.3. Bile Acids

9.2.1.4. H. pylori SA

9.2.1.5. Pancreatic Elastase

9.2.1.6. Others

9.2.2. Analyzers

9.3. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

9.3.1. Diagnostic Laboratories

9.3.2. Hospitals

9.3.3. Research Institutes

9.4. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country, 2018–2030

9.4.1. U.S.

9.4.2. Canada

9.5. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

9.5.1. By Product

9.5.2. By End-user

9.5.3. By Country

10. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

10.1. Introduction

10.2. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

10.2.1. Assays/Biomarker

10.2.1.1. Calprotectin

10.2.1.2. Lactoferrin

10.2.1.3. Bile Acids

10.2.1.4. H. pylori SA

10.2.1.5. Pancreatic Elastase

10.2.1.6. Others

10.2.2. Analyzers

10.3. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

10.3.1. Diagnostic Laboratories

10.3.2. Hospitals

10.3.3. Research Institutes

10.4. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

10.5.1. By Product

10.5.2. By End-user

10.5.3. By Country/Sub-region

11. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

11.1. Introduction

11.2. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

11.2.1. Assays/Biomarker

11.2.1.1. Calprotectin

11.2.1.2. Lactoferrin

11.2.1.3. Bile Acids

11.2.1.4. H. pylori SA

11.2.1.5. Pancreatic Elastase

11.2.1.6. Others

11.2.2. Analyzers

11.3. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

11.3.1. Diagnostic Laboratories

11.3.2. Hospitals

11.3.3. Research Institutes

11.4. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

11.5.1. By Product

11.5.2. By End-user

11.5.3. By Country/Sub-region

12. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

12.1. Introduction

12.2. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

12.2.1. Assays/Biomarker

12.2.1.1. Calprotectin

12.2.1.2. Lactoferrin

12.2.1.3. Bile Acids

12.2.1.4. H. pylori SA

12.2.1.5. Pancreatic Elastase

12.2.1.6. Others

12.2.2. Analyzers

12.3. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

12.3.1. Diagnostic Laboratories

12.3.2. Hospitals

12.3.3. Research Institutes

12.4. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

12.5.1. By Product

12.5.2. By End-user

12.5.3. By Country/Sub-region

13. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Analysis and Forecast

13.1. Introduction

13.2. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Product, 2018–2030

13.2.1. Assays/Biomarker

13.2.1.1. Calprotectin

13.2.1.2. Lactoferrin

13.2.1.3. Bile Acids

13.2.1.4. H. pylori SA

13.2.1.5. Pancreatic Elastase

13.2.1.6. Others

13.2.2. Analyzers

13.3. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2018–2030

13.3.1. Diagnostic Laboratories

13.3.2. Hospitals

13.3.3. Research Institutes

13.4. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Attractiveness Analysis

13.5.1. By Product

13.5.2. By End-user

13.5.3. By Country/Sub-region

14. Competition Landscape

14.1. Market Position Analysis, by Company, 2019

14.2. Company Profiles

14.2.1. DiaSorin S.p.A

14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.1.2. Company Financials

14.2.1.3. Growth Strategies

14.2.1.4. SWOT Analysis

14.2.2. F. Hoffmann-La Roche Ltd

14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.2.2. Company Financials

14.2.2.3. Growth Strategies

14.2.2.4. SWOT Analysis

14.2.3. Siemens Healthineers AG

14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.3.2. Company Financials

14.2.3.3. Growth Strategies

14.2.3.4. SWOT Analysis

14.2.4. Abbott

14.2.4.1. Company Overview (HQ, Business Segments)

14.2.4.2. Company Financials

14.2.4.3. Growth Strategies

14.2.4.4. SWOT Analysis

14.2.5. Quidel Corporation

14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.5.2. Company Financials

14.2.5.3. Growth Strategies

14.2.5.4. SWOT Analysis

14.2.6. BÜHLMANN Laboratories AG

14.2.6.1. Company Overview (HQ, Business Segments)

14.2.6.2. Growth Strategies

14.2.6.3. SWOT Analysis

14.2.7. American Laboratory Products Company (ALPCO)

14.2.7.1. Company Overview (HQ, Business Segments)

14.2.7.2. Growth Strategies

14.2.7.3. SWOT Analysis

14.2.8. Certest Biotec SL

14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.8.2. Growth Strategies

14.2.8.3. SWOT Analysis

14.2.9. Biosystems S.A.

14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.9.2. Growth Strategies

14.2.9.3. SWOT Analysis

List of Tables

Table 01: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 02: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030

Table 03: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 04: Global In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 05: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 06: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 07: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarker, 2018–2030

Table 08: North America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 09: Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 10: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 11: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030

Table 12: Europe In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 13: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 15: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030

Table 16: Asia Pacific In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 17: Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 19: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarkers, 2018–2030

Table 20: Latin America In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 21: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 22: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 23: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by Assays/Biomarker, 2018–2030

Table 24: Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030